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In the present study we have studied the effect of 25, 50, 75 and 100 µM of luteolin on the transgenic 
Drosophila expressing human alpha synuclein. The doses of luteolin were established in diet and the PD 
flies were allowed to feed on it for 24 days. After 24 days of exposure the flies were assayed for climbing 
assay, oxidative stress markers, caspase-3 & 9 activity and dopamine content. The immunohistochemistry 
was also performed on the brain sections for the activity of tyrosine hydroxylase. The exposure of luteolin 
showed a dose dependent delay in the loss of climbing ability and activity, reduction in oxidative stress 
markers, caspase-3&9 activities and results in an increase in the dopamine content. The results obtained 
for the immunohistochemistry also supports the protective role of luteolin against the damage of the 
dopaminergic neurons. 
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INTRODUCTION
Parkinson’s disease (PD) is a common progressive 
neurodegenerative disorder characterized by the loss of 
dopaminergic neurons due to the over expression of alpha 
synuclein and formation of the Lewy bodies (Shaltiel-
Karyo et al., 2012). The loss of the dopaminergic 
neurons has been implicated in causing severe motor 
symptoms (Jenner, Olanow, 2006). Lewy bodies are 
spherical protein inclusions found in the cytoplasm 
of surviving neurons and consisted of a dense core 
surrounded by a halo of radiating fibrils of α-synuclein 
(Meng et al., 2010). The formation of Lewy bodies has 
been linked with the production of reactive oxygen 
species (ROS) leading to a state of oxidative stress 
producing superoxide radical anions, hydrogen peroxide 
and hydroxyl radicals (Thomas, Beal, 2007; Cookson, 
2005; Auluck et al., 2002). There are enough evidences 
showing an increase of oxidative stress during the 
progression of neurodegenerative diseases such as 
Parkinson’s and Alzheimer’s disease (Marsh, Thompson, 
2006; Filomeni et al., 2012; Behl, Holsboer, 1998). 
Oxidative stress has also been implicated in neuronal 
loss associated with cognitive decline. The potential 
role of ROS and reactive nitrogen species (RNS) in 
the pathophysiology of neurodegenerative disorder 
is relevant as nitric oxide (NO·) and superoxide (O2·-) 
may be generated in the brain and their formation is 
often co-localised in specific neurons (Youdim et al., 
2002). Recently, there has been a considerable attention 
for establishing a therapeutic and dietary strategy 
to combat oxidative stress during the progression of 
neurodegenerative diseases. In this context a number 
of dietary antioxidants especially flavonoids have been 
screened for their biological actions (Singh, Rajini, 2004; 
Seidl et al., 2014). As there is no preventive therapy for 
the neurodegenerative diseases till date, hence any agent 
that can slow /or prevent aggregation and fibrillation of 
α-synuclein or reduced the oxidative stress could act as 
a possible therapeutic agent. Luteolin is a polyphenolic 
compound found in celery, green pepper, perilla leaf and 
camomile tea (Chen et al., 2008). It has been reported to 
possess anti-mutagenic, anti-tumorigenic, antioxidant 
and anti-inflammatory properties but the investigations 
exploring its nature on the neurodegenerative disorders 
are warranted. The present study deals with the effect of 
luteolin on the PD model flies expressing human alpha 
synuclein in the brain. 
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MATERIAL AND METHODS
Drosophila stocks
Transgenic fly lines that express wild-type 
human synuclein (h-αS) under UAS control in neurons 
‘‘[w[*];P{w[+mC]=UAS–Hsap/SNCA.F}’’5B and GAL4 
‘‘w[*];P{w[+mC]=GAL4- elavL}’’3] were obtained 
from Bloomington Drosophila Stock Centre (Indiana 
University, Bloomington, IN). When the males of UAS 
(Upstream Activation Sequence)-Hsap/SNCA.F strains 
are crossed with the females of GAL4-elav. L (vice-versa), 
the progeny will express human αS in the neurons (Feany, 
Bender, 2000).
Drosophila culture and crosses
The flies were cultured on standard Drosophila 
food containing agar, corn meal, sugar and yeast at 25 °C 
(24 ± 1) (Siddique et al., 2014). Crosses were set up as 
described in our earlier published work (Siddique et al., 
2012). The PD flies were allowed to feed separately on 
different doses of luteolin (Sigma, USA) mixed in the diet. 
Luteolin was added in the diet at final concentration of 25, 
50, 75 and 100 µM. The PD flies were also exposed to 10-3 
M of L-dopamine. The UASHsap/ SNC.F act as a control. 
The control flies were allowed separately to feed on the 
selected doses of luteolin. Fly heads from each group were 
isolated (50 heads/group; five replicates/group) and the 
homogenate was prepared in 0.1 M phosphate buffer for 
the biochemical parameters.
Antioxidative assays
Two assays were used for estimating the antioxidative 
potential of luteolin for the doses selected in our study
Superoxide anion scavenging assay
The inhibition of Nitroblue tetrazolium (NBT) 
reduction by phenazine methosulphate (PMS) generated 
O2·- was used to determine the superoxide anion 
scavenging activity of the luteolin (Sghaier et al., 
2011) The reaction mixture consist of 75 µL of each 
concentration of luteolin, 750 µL of Tris HCl (100 mM; 
pH 7.4); 187 µL of NBT (300 µM), 187 µL of NADH 
(936 µM). The reaction was initiated by adding phenazine 
methosulphate (PMS) (120 µM). The reaction mixture 
was incubated at 25 ºC for 5 min and the OD was read at 
560 nm and the degree of scavenging was calculated by 
the following equation:
Diphenyl-picrylhydrazyl (DPPH) free radical 
scavenging
For estimating free radical scavenging potential of 
the luteolin DPPH method as described by Wongsawatkul 
et al. (2008) was used in the present study. When DPPH (a 
stable purple color) react with an antioxidant, it is reduced 
to yield a light yellow coloured diphenyl picrylhydrazine. 
Color change was spectrophotometrically measured. 
The reaction mixture consisting of 500 µL of luteolin 
and 250 µL of DPPH (0.3 mM). The reaction mixture 
was shaken vigorously and allowed to stand at room 
temperature in the dark for 25 min. The OD was read at 
518 nm and the radical scavenging activity was calculated 
by the following equation:
% Radical scavenging = (1-Absorbance of sample/
Absorbance of control) x 100
Drosophila climbing assay
The climbing assay was performed as described by 
Pendleton et al. (2002). Ten flies were placed in an empty 
glass vial (10.5 cm × 2.5 cm). A horizontal line was drawn 
8 cm above the bottom of the vial. After the flies had 
acclimated for 10 min at room temperature, both controls 
and treated groups were assayed at random to a total of 
10 trails for each. The mean values were calculated and 
then averaged, and a group mean and standard error were 
obtained. All behavioral studies were performed at 25 °C 
under standard lighting conditions.
Drosophila activity pattern
From the 12th day the activity of flies (males) in all 
treated groups were analyzed by using Drosophila Activity 
Monitor (TriTek, USA). The activity was recorded every 
hour for a total of 287 h and the data was analyzed by 
Actogram J software. The results were presented as chi-
square periodogram (Rasato, Kyriacou, 2006).
Estimation of glutathione (GSH) content
The GSH content was estimated colorimetrically 
using Ellman’s reagent (DTNB) according to the procedure 
described by Jollow et al. (1974). The supernatant was 
precipitated with 4% sulphosalicyclic acid in the ratio 
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of 1:1. The samples were kept at 4 ºC for 1 hr and then 
subjected to centrifugation at 4200g for 10 min at 4 ºC. 
The assay mixture consisted of 550 µL of 0.1 M phosphate 
buffer, 100 µL of supernatant and 100 µL of DTNB. The 
OD was read at 412 nm and the results were expressed as 
µ moles of GSH/gram tissue.
Estimation of glutathione-S-transferase (GST) 
activity
The GST activity was determined by the method 
of Habig et al. (1974). The reaction mixture consisted 
of 500 µL of 0.1 M phosphate buffer, 150 µL of 10 mM 
CDNB, 200 µL of 10 mM reduced glutathione and 50 µL 
of supernatant. The OD was taken at 340 nm and the 
enzyme activity was expressed as µ moles of CDNB 
conjugates/min/mg protein.
Lipid peroxidation assay (LPO)
LPO was measured according to the method 
described by Ohkawa, Nobuko, Yagi (1978). The reaction 
mixture consisted of 5 µL of 10 mM butyl-hydroxytoluene 
(BHT), 200 µL of 0.67% thiobarbituric acid, 600 µL of 1% 
O-phosphoric acid, 105 µL of distilled water and 90 µL of 
supernatant. The resultant mixture was incubated at 90 ºC 
for 45 min and the OD was measured at 535 nm. The results 
were expressed as µmol of TBARS formed/h/g tissue.
Estimation of Protein Carbonyl content (PCC)
The PCC was estimated according to the protocol 
described by Hawkins, Morgan, Davies (2009). The 
brain homogenate was diluted to a protein concentration 
of approx 1 mg/mL. About 250 µL of each diluted 
homogenate was taken in eppendorf centrifuge tubes 
separately. To it 250 µL of 10 mM 2, 4-dinitrophenyl 
hydrazine (dissolved in 2.5 M HCl) was added, vortexed 
and kept in dark for 20 min. About 125 µL of 50% (w/v) 
trichloroacetic acid (TCA) was added, mixed thoroughly 
and incubated at -20 °C for 15 min. The tubes were then 
centrifuged at 4 °C for 10 min at 8200 g. The supernatant 
was discarded and the pellet obtained was washed twice 
by ice cold ethanol: ethyl acetate (1:1). Finally, the pellets 
were re-dissolved in 1ml of 6 M guanidine hydrochloride 
and the absorbance was read at 370 nm.
Assay for caspase-3 (Drice) and caspase-9 
(Dronc) activities
For estimating the activities of caspase 3 and 9 
the assay was performed according to the manufacturer 
protocol with some modification (Bio-Vision, CA, USA). 
The assay was based on spectrophotometric detection 
of the chromophore p-nitroanilide (pNA) obtained after 
specific action of caspase-3 and caspase-9 on tetrapeptide 
substrates, DEVD-pNA and IETD-pNA, respectively. The 
assay mixture consisted of 50 µL of fly head homogenate 
from each group and 50 µL of chilled cell lysis buffer 
incubated on ice for 10 min. After incubation, 50 µL of 
two times reaction buffer (containing 10mM DTT) with 
200 µM substrate (DEVD-pNA for Drice, and IETD-pNA 
for Dronc) was added and incubated at 37 ºC for 1.5 h. The 
reaction was quantified at 405nm. 
Dopamine content
Dopamine content was measured as per method 
described by Schlumpf et al. (1974). Fifty heads of 
flies from each group were taken in 500 µL of HCl-
butanol (0.85 mL of 37% HCl in 1 litre n-butanol). After 
homogenization the samples were centrifuged at 2200 g 
for 5 min. After collecting the supernatant, 250 µL of 
heptane and 100 µL of 0.1 M HCl were added. The 
samples were vortexed and centrifuged at 2200g for 5 min. 
The upper organic phase was discarded and the lower 
aqueous phase was kept for dopamine assay. To 100 µL 
of aqueous phase, 50 µL 0.4 M HCl, 100 µL of sodium 
acetate buffer (pH 6.9), 100 µL of iodine solution was 
added and kept for two min. The reaction was stopped by 
adding of 100 µL of sodium sulphite solution. After two 
min, 100 µL of acetic acid (10 M) was added and then the 
mixture was heated at 100 ºC for 6 min. The OD was taken 
at 375 nm after cooling the samples at room temperature.
Immunohistochemistry
The fly heads were isolated and paraffin sections 
were prepared according to the procedure described by 
Palladino et al. (2000). The sections were deparaffinized 
and rehydrated. The slides were blocked in 8% Bovine 
Serum Albumin (BSA) for 2.5hr. Then the slides 
were washed with phosphate buffer saline (pH 7.2) 
containing 2% BSA for 5 minutes. After washing the 
slides were incubated with primary antibody (anti-tyrosine 
hydroxylase, Merck) in a humidified chamber for 12 hr at 
4 ºC. The slides were then washed with PBS containing 
2% BSA for 5 min and incubated with secondary antibody 
(Goat anti-Rabbit alkaline phosphatase, Santacruz, 
Biotechnology, USA) at room temperature for 2 h. The 
final wash was given by PBS containing 2% BSA for 
5 min. BCIP-NBT was used as a chromogenic substrate 
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which interacts with secondary antibody to produce blue 
coloured product. The slides were then mounted in DPX 
and observed under the microscope.
Statistical analysis
The statistical analysis was done by performing one-
way ANOVA post hoc test using SPSS Ver. 16. 
RESULTS 
The result obtained for superoxide anion scavenging 
activity is shown in Figure 1S. A clear dose dependent 
significant increase in the superoxide anion scavenging 
activity of luteolin was observed at 25, 50, 75 and 
100 µM compared to control. The results obtained for free 
radical scavenging also showed similar results. A clear 
dose dependent significant increase in the free radical 
scavenging activity of luteolin was observed at 25, 50, 75 
and 100 µM compared to control (Figure 2S). The results 
obtained for the average activity pattern are shown in 
Figure (3S-13S). The activity of flies was recorded for 
287hrs and then with the help of software programme 
was present in the form of average activity pattern and 
chi-square periodogram. The PD flies showed a decrease 
in the average activity (Figure 4S) compared to control 
flies (Figure 3S) which is evident by the chi-square 
periodogram. The numbers of peaks are more near the 
midline. The exposure of PD flies to 25, 50, 75 and 100 µM 
of luteolin showed a dose dependent delay in the loss of 
activity as is evident from chi-square periodogram (Figure 
5S-8S). The control flies showed no change in the activity 
when exposed to 25, 50, 75 and 100 µM of luteolin (Figure 
9S-12S). The PD flies exposed to 10-3 M of dopamine 
also showed a delay in the loss of activity compared to 
unexposed PD flies (Figure 13S). 
The results obtained for the climbing ability of PD 
flies showed a significant 4.5 fold of decrease compared 
to control flies (Figure 1; p<0.05). The exposure of PD 
flies to 25, 50, 75 and 100µM of luteolin showed a dose 
dependent significant delay in the loss of climbing ability 
of 1.52, 1.85, 2.19 and 2.67 folds compared to the PD 
flies (Figure 1; p<0.05). The PD flies exposed to 10-3 M of 
dopamine showed a 3.04 fold significant delay in the loss 
of climbing ability compared to the PD flies (Figure 1; 
p<0.05). The GSH content of PD flies showed a significant 
decrease of 1.98 fold compared to the control flies (Figure 2; 
p<0.05). The PD flies exposed to 25, 50, 75 and 100 µM of 
luteolin showed a dose dependent 1.10, 1.31, 1.48 and 1.64 
folds of significant increase in the GSH content compared 
to unexposed PD flies (Figure 2; p<0.05). The exposure 
of PD flies to 10-3M of dopamine showed a 1.32 fold of 
significant increase in the GSH content compared to PD 
flies (Figure 2; p<0.05). PD flies showed a 2.53 fold of 
increase in the GST activity compared to control flies 
(Figure 3; p<0.05). The PD flies exposed to 25, 50, 75 
and 100 µM of luteolin showed a 1.11, 1.19, 1.25 and 
1.45 folds of significant decrease in the GST activity 
compared to unexposed PD flies (Figure 3; p<0.05). The 
PD flies exposed to 10-3 M of dopamine showed a 1.67 
fold of significant decrease in the GST activity compared 
to unexposed PD flies (Figure 3; p<0.05). The PD flies 
showed a 5.16 fold significant increase in LPO compared 
to control flies (Figure 4; p<0.05). The exposure of PD 
flies to 25, 50, 75 and 100µM of luteolin showed a dose 
dependent 1.21, 1.47, 1.77 and 2.13 folds of significant 
decrease respectively in the LPO (Figure 4; p<0.05). The 
PD flies exposed to 10-3M of dopamine showed a 1.93 fold 
of significant decrease in LPO compared to unexposed PD 
flies (Figure 4; p<0.05). The PD flies showed 3.81 fold of 
significant increase in PC content compared to control flies 
(Figure 5; p<0.05). The PD flies exposed to 25, 50, 75 and 
100 µM of luteolin showed a dose dependent significant 
decrease of 1.16, 1.40, 1.61 and 2.1 folds respectively 
compared to unexposed PD flies (Figure 5; p<0.05). 
The PD flies exposed to 10-3M of dopamine showed a 
significant decrease of 2.0 fold in the PC content compared 
to unexposed PD flies (Figure 5; p<0.05). The PD flies 
showed a 4.33 fold significant increase in the activity of 
caspase-9 compared to control flies (Figure 6; p<0.05). 
The PD flies exposed to 25, 50, 75 and 100µM of luteolin 
showed a dose dependent significant decrease of 1.3, 1.5, 
1.95 and 2.29 folds respectively compared to unexposed 
PD flies (Figure 6; p<0.05). The PD flies exposed to 10-3 M 
of dopamine showed a 2.43 fold of significant decrease in 
the caspase-9 compared to unexposed PD flies (Figure 6; 
p<0.05). Similarly, PD flies showed a significant increase 
of 2.90 fold in the activity of caspase-3, compared to 
control flies (Figure 7; p<0.05). The exposure of 25, 50, 
75 and 100 µM of luteolin showed a significant decrease 
of 1.23, 1.39, 1.60 and 1.88 folds respectively compared 
to unexposed PD flies (Figure 7; p<0.05). The exposure 
of PD flies to 10-3 M of dopamine showed a 1.88 fold 
of significant decrease compared to PD flies (Figure 7; 
p<0.05). A significant decrease of 2.7 fold was observed 
in the dopamine content in PD flies compared to control 
flies (Figure 8; p<0.05). The PD flies exposed to 25, 50, 
75 and 100 µM of luteolin showed a significant increase 
of 1.2, 1.3, 1.5 and 1.7 folds respectively in the dopamine 
content (Figure 8; p<0.05). The PD flies exposed to 10-3 M 
of dopamine showed a significant increase of 1.9 fold in 
the dopamine content compared to PD flies (Figure 8; 
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p<0.05). The results obtained for immunohistochemistry 
are depicted in Figure 9(A-C). The less activity of 
tyrosine hydroxylase was observed in PD flies (Figure 
9A) compared to control flies (Figure 9B). The exposure 
to various doses of luteolin showed a higher activity of 
tyrosine hydroxylase compared to unexposed PD flies 
(Figure 9C).
DISCUSSION
The results of the present study reveal that luteolin 
not only reduced the oxidative stress but also delayed 
the loss of climbing ability of the PD model flies. PD 
flies exposed to luteolin also exhibit delay in the loss 
of climbing ability in a dose dependent manner. The 
results obtained for activity pattern also suggest that the 
exposure of PD flies to luteolin showed a dose dependent 
delay in the loss of activity. There are evidences which 
supports that dietary derived flavonoids have the 
potential to improve human memory and neuro-cognitive 
performance via their ability to protect vulnerable 
neurons, enhancing neuronal function and stimulate the 
neuronal regeneration (Spencer, 2008). Luteolin has been 
reported to improved cognitive impairments in rats and 
mice (Liu et al., 2013; Jang, Dilger, Johnson, 2010; Xu 
et al., 2010). 
FIGURE 1 - Effect of luteolin on the climbing ability. [L1= 25 
µM; L2= 50 µM; L3 = 75 µM; L4=100 µM; PD = PD flies; 
Dopamine=10-3 M]. The flies were allowed to feed on the 
diet supplemented with luteolin for 24 days and then assayed 
for climbing ability. The values are the mean of 5 assays. 
[a - significant at p<0.05 compared to control; b - significant at 
p<0.05 compared to PD flies].
FIGURE 2 - Effect of luteolin on the glutathione (GSH) content 
in the brains of flies. [L1= 25 µM; L2= 50 µM; L3 = 75 µM; 
L4= 100 µM; PD = PD flies; Dopamine=10-3 M]. The flies 
were allowed to feed on the diet supplemented with luteolin for 
24 days and then assayed for GSH content. The values are the 
mean of 5 assays. [a - significant at p<0.05 compared to control; 
b - significant at p<0.05 compared to PD flies].
FIGURE 3 - Effect of luteolin on the glutathione-S-transferase 
(GST) activity in the brains of flies. [L1= 25 µM; L2= 50 µM; L3 
= 75 µM; L4= 100 µM; PD = PD flies; Dopamine=10-3 M]. The 
flies were allowed to feed on the diet supplemented with luteolin 
for 24 days and then assayed for GST activity. The values are the 
mean of 5 assays. [a - significant at p<0.05 compared to control; 
b - significant at p<0.05 compared to PD flies].
FIGURE 4 - Effect of luteolin on the lipid peroxidation in 
the brains of flies. [L1 = 25 µM; L2 = 50 µM; L3 = 75 µM; 
L4 = 100 µM; PD = PD flies; Dopamine = 10-3 M]. The flies were 
allowed to feed on the diet supplemented with luteolin for 24 
days and then assayed for lipid peroxidation. The values are the 
mean of 5 assays. [a - significant at p<0.05 compared to control; 
b - significant at p<0.05 compared to PD flies].
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Oxidative stress is the key component of the 
pathology of neurodegenerative disorders (Aruoma, 
Bahorun, Jen, 2003). During the past several years there 
has been a tremendous progress in the understanding the 
causative factors for various neurodegenerative disorders 
but there have been no therapies available that benefits 
patient suffering from these diseases (Solanki et al., 2015). 
It is well accepted that the accumulation of intracellular 
damage by ROS might orchestrate the progressive loss 
of control over biological homeostasis (Cencioni et al., 
2013). 
GSH is a tripeptide present in the majority of cells, 
is responsible for hydrophilic xenobiotics conjugation 
sulphydryl group of glutathione is essential for its 
antioxidant activity against the ROS in cells (Durgo et 
al., 2007). GSH is one of the essential compounds for 
maintaining cell integrity against ROS and as being non 
enzymatic free radical scavenger, it participates in the 
detoxification of ROS and reduces H2O2 (Waseem, Parvez, 
2013). A decrease in the GSH content has been reported 
in PD patients due to the neuronal loss. This decrease in 
GSH would reduce the capacity of the neurons to detoxify 
not only hydrogen peroxide but also lipid hydroperoxides 
and increase the risk of free radical formation and lipid 
peroxidation (Sofic et al., 1992). There are evidences that 
some flavonoids can enhance the intracellular basal level 
FIGURE 5 - Effect of luteolin on the protein carbonyl content 
measured in the brains of flies. [L1= 25 µM; L2= 50 µM; L3 = 
75 µM; L4= 100 µM; PD = PD flies; Dopamine=10-3 M]. The 
flies were allowed to feed on the diet supplemented with luteolin 
for 24 days and then assayed for lipid peroxidation. The values 
are the mean of 5 assays. [a - significant at p<0.05 compared to 
control; b - significant at p<0.05 compared to PD flies].
FIGURE 7 - Effect of luteolin on caspase-3 activity in the brains 
of flies. [L1= 25 µM; L2= 50 µM; L3 = 75 µM; L4= 100 µM; 
PD = PD flies; Dopamine=10-3 M]. The flies were allowed to 
feed on the diet supplemented with luteolin for 24 days and 
then assayed for caspase-3 activity. The values are the mean 
of 5 assays. [a - significant at p<0.05 compared to control; 
b - significant at p<0.05 compared to PD flies].
FIGURE 6 - Effect of luteolin on caspase-9 activity in the brains 
of flies. [L1= 25 µM; L2= 50 µM; L3 = 75 µM; L4= 100 µM; 
PD = PD flies; Dopamine=10-3 M]. The flies were allowed to 
feed on the diet supplemented with luteolin for 24 days and 
then assayed for caspase-9 activity. The values are the mean 
of 5 assays. [a - significant at p<0.05 compared to control; 
b - significant at p<0.05 compared to PD flies].
FIGURE 8 - Effect of luteolin on dopamine content measured in 
the brains of flies. [L1= 25 µM; L2= 50 µM; L3 = 75 µM; L4= 
100 µM; PD = PD flies; Dopamine=10-3 M]. The flies were 
allowed to feed on the diet supplemented with luteolin for 24 
days and then assayed for dopamine content. The values are the 
mean of 5 assays. [a - significant at p<0.05 compared to control; 
b - significant at p<0.05 compared to PD flies].
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of GSH, thereby promoting the tolerance against free 
radicals (Cipak et al., 2003). The exposure of luteolin to 
PD flies showed a dose dependent increase in the GSH 
content. 
Free radicals may also attack unsaturated lipids 
in a cell, resulting in the chain reaction leading to the 
breakdown products such as malondialdehyde (MDA). 
The measurement of MDA concentration is a common 
method for the determination of LPO. The exposure of 
luteolin to the PD flies showed a dose dependent decrease 
in the LPO. GST family of genes has been implicated in 
multiple neurodegenerative disorders (Allen et al., 2012). 
The altered level or functions of GST has been associated 
with the oxidative stress in a way that contributes the 
progression of the disease (Allen et al., 2012). In our study 
the PD flies were associated with an increased activity of 
GST. The exposure of luteolin to PD flies showed a dose 
dependent decrease in the activity of GST. The increase 
in the GST activity has also been reported to rescue the 
dopaminergic neurons in Drosophila (Whitworth et 
al., 2005). Protein oxidation has been implicated in the 
pathogenesis of various human diseases (Dalle-Donne 
et al., 2013). Oxidative damage to protein modifies its 
symmetrical arrangements via aggregation, fragmentation 
and formation of cross linkages in the polypeptide chain 
which further extends the generation of superoxide radical 
(Waseem, Parvez, 2013; Chen et al., 2005). In our study 
the PD flies showed a higher content of PC compared 
to control flies and the exposure of PD flies to luteolin 
showed a dose dependent decrease in the PC content. In 
our study the activity of caspase-3 and 9 were found to 
be elevated in the brain of PD flies. The flies exposed to 
luteolin showed a dose dependent decrease in the activity 
of caspase 3 and 9. Apoptotic neuronal death plays an 
important PD (Guo et al., 2013). In number of studies 
besides showing the antioxidative properties luteolin has 
shown anti-apoptotic properties (Guo et al., 2013; Zhu et 
al., 2011; Lin et al., 2010; Kim, Chin, Cho, 2017). 
Many plant polyphenolic compounds possess anti-
oxidative as well as other biological activities (Yang et 
al., 1997). We have estimated the potential of luteolin 
in scavenging the ROS by performing superoxide anion 
scavenging and DPPH assay. Both the assays showed 
that luteolin have a significant potential in scavenging the 
ROS at the doses used in our present study. The results 
obtained for the immunostaining for tyrosine hydroxylase 
also showed the presence of dopaminergic neurons in the 
PD flies exposed to various doses of luteolin. The results 
clearly demonstrates that the luteolin effectively provide 
protection to the neurons by reducing the oxidative stress. 
The exposure of luteolin showed a dose dependent 
increase in the dopamine content in the brains of PD 
flies. Luteolin showed the protection of dopaminergic 
neurons by inhibiting the microglial activation and 
thereby preventing the generation of tumor necrosis 
factor-α, nitric oxide and superoxide (Chen et al., 2008). 
A decrease in dopamine content is associated with the 
progressive degeneration of dopaminergic neurons 
(Rekha et al., 2013). Tyroxine hydroxylase is the rate 
limiting enzyme for the formation of dopamine. In our 
present study its expression was used to identify surviving 
dopaminergic neurons (Jackson-Lewis et al., 1995).
Tyroxine hydroxylase immuno-reactivity describes the 
number of survival neurons. PD patients generally show 
a decrease in the activity of tyroxine hydroxylase, being 
more pronounced in the nigrostraital system (Rausch et 
al., 1988). Considering our results in the present study 
the localization of tyroxine hydroxylase in PD flies 
exposed to luteolin further strengthens and supports the 
protective role of luteolin in the flies expressing human 
alpha synuclein. Using Drosophila as a study model, 
one can easily analyze the pharmacological properties of 
plants/ plant derived components by performing several 
assays. The pharmacological properties of various natural 
plant products using Drosophila as a model have been 
extensively reviewed by Panchal and Tiwari (2017). Our 
earlier studies using the same study model on flavonoids/ 
plant extracts (Fatima et al., 2017; Siddique et al., 
2016; Siddique, Naz, Jyoti, 2014) have also shown the 
promising results in reducing the PD symptoms. Hence, 
it is concluded that the luteolin is potent in reducing the 
PD symptoms in transgenic Drosophila expressing human 
alpha synuclein in the neurons. 
FIGURE 9 - Immunohistochemistry performed on the brain 
sections using anti-tyrosine hydroxylase (primary antibody) and 
alkaline phosphatase (secondary antibody). BCIP-NBT solution 
was used as a substrate (100X) [A-PD fly; B-Control; C-PD fly 
exposed to 100 µM of luteolin].
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CONCLUSION
It is concluded that luteolin is potent in reducing the 
PD symptoms in transgenic Drosophila expressing human 
alpha synuclein in the neurons. 
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FIGURE 1S - Super oxide anion scavenging activity of luteolin. 
The values are the mean of five assays [*significant with respect 
to control, p<0.05].
FIGURE 2S - Free radical scavenging activity of luteolin. The 
values are the mean of five assays [*significant with respect to 
control, p<0.05].
SUPPLEMENTARY FIGURES
FIGURE 3S - (a) and (b) shows the average activity pattern and chi-square periodogram respectively for control flies (N=20).
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FIGURE 4S - (a) and (b) shows the average activity pattern and chi-square periodogram respectively for PD flies (N=20).
FIGURE 5S - (a) and (b) shows the average activity pattern and chi-square periodogram respectively for PD flies exposed to luteolin 
(25 µM).
FIGURE 6S - (a) and (b) shows the average activity pattern and chi-square periodogram respectively for PD flies exposed to luteolin 
(50 µM).
FIGURE 7S - (a) and (b) shows the average activity pattern and chi-square periodogram respectively for PD flies exposed to luteolin 
(75 µM).
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FIGURE 8S - (a) and (b) shows the average activity pattern and chi-square periodogram respectively for PD flies exposed to luteolin 
(100 µM).
FIGURE 9S - (a) and (b) shows the average activity pattern and chi-square periodogram respectively for Control flies exposed to 
luteolin (25 µM).
FIGURE 10S - (a) and (b) shows the average activity pattern and chi-square periodogram respectively for Control flies exposed 
to luteolin (50 µM).
FIGURE 11S - (a) and (b) shows the average activity pattern and chi-square periodogram respectively for Control flies exposed 
to luteolin (75 µM).
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FIGURE 12S - (a) and (b) shows the average activity pattern and chi-square periodogram respectively for Control flies exposed 
to luteolin (100 µM).
FIGURE 13S - (a) and (b) shows the average activity pattern and chi-square periodogram respectively for PD flies exposed to 
dopamine (10-3 M).
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